Does fluoxetine (selective serotonin reuptake inhibitor) affect testosterone level testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Fluoxetine Affect Testosterone Level Testing?

Fluoxetine does not interfere with the laboratory measurement of testosterone levels, but it can cause actual decreases in serum testosterone concentrations in some patients, which would be accurately reflected in testing results.

Laboratory Testing Interference vs. Biological Effect

The available evidence does not indicate that fluoxetine causes false readings or analytical interference with testosterone assays. However, fluoxetine can produce real biological changes in testosterone levels that laboratory testing will accurately detect 1, 2.

Clinical Evidence on Testosterone Changes

Human Studies

  • In a study of 44 men with major depressive disorder treated with fluoxetine for 12 weeks, no significant changes in mean testosterone levels occurred (448.4 ± 139.6 to 439.5 ± 142.1 ng/dL, p > 0.05), and none of the men developed low testosterone levels 1.

  • A smaller pilot study of 11 depressed patients on fluoxetine 20 mg/day for 1 month found no consistent relationship between fluoxetine treatment and testosterone levels at the population level (p = 0.4), though individual patients showed variable increases and decreases 2.

  • The same study found that in patients with higher depression severity (BDI ≥ 20), baseline testosterone levels were highly associated with apathy levels (p = 0.0033), suggesting testosterone may influence depressive symptoms independent of fluoxetine effects 2.

Mechanistic and Animal Data

  • In vitro studies using H295R adrenocortical cells demonstrated that fluoxetine and other SSRIs decreased testosterone production at concentrations around therapeutic Cmax levels, with effects on CYP17 enzyme activity and increased estrogen/androgen ratios 3.

  • Animal studies in rats showed that chronic fluoxetine administration (200 mg/kg for 60 days) caused significant decreases in testosterone and FSH levels, along with impaired spermatogenesis 4, 5.

Clinical Implications for Testosterone Testing

When ordering testosterone testing in patients on fluoxetine:

  • The laboratory assay will accurately measure circulating testosterone levels without analytical interference 1, 2.

  • If low testosterone is detected, consider that fluoxetine may be contributing to the reduction, though human evidence shows this effect is inconsistent and not universal 1, 2.

  • Testosterone testing remains clinically indicated in patients with sexual dysfunction on fluoxetine, as guidelines recommend testosterone therapy when total morning testosterone is <300 ng/dL and there are no contraindications 6.

Important Caveats

  • The human studies showing minimal testosterone effects used standard therapeutic doses (10-20 mg/day) for relatively short durations (1-3 months) 1, 2.

  • Individual patient responses vary considerably, with some patients showing testosterone increases and others showing decreases during fluoxetine treatment 2.

  • The in vitro and animal data suggest potential for testosterone suppression, but these findings may not translate directly to clinical practice at therapeutic doses 4, 5, 3.

References

Research

Fluoxetine treatment and testosterone levels.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2006

Research

The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.

Toxicology in vitro : an international journal published in association with BIBRA, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.